HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5142.46M
Enterprise Value 3196.85M
Trailing P/E N/A
Forward P/E 114.15
PEG Ratio (5 yr expected) 11.86
Price/Sales (ttm)1.07
Price/Book (mrq)1.76
Enterprise Value/Revenue 31.48
Enterprise Value/EBITDA 619.05

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin -3.60%
Operating Margin (ttm)2.97%

Management Effectiveness

Return on Assets (ttm)1.79%
Return on Equity (ttm)-8.19%

Income Statement

Revenue (ttm)133.04M
Revenue Per Share (ttm)3.71
Quarterly Revenue Growth (yoy)53.00%
Gross Profit (ttm)47.6M
EBITDA 10.33M
Net Income Avi to Common (ttm)-6.46M
Diluted EPS (ttm)-0.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.66M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)61.05M
Total Debt/Equity (mrq)75.40
Current Ratio (mrq)2.83
Book Value Per Share (mrq)2.17

Cash Flow Statement

Operating Cash Flow (ttm)-648k
Levered Free Cash Flow (ttm)8.86M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.07
52-Week Change 3-20.85%
S&P500 52-Week Change 31.08%
52 Week High 36.70
52 Week Low 32.75
50-Day Moving Average 33.32
200-Day Moving Average 34.38

Share Statistics

Avg Vol (3 month) 3104.58k
Avg Vol (10 day) 3107.34k
Shares Outstanding 537.29M
Float 32.49M
% Held by Insiders 112.30%
% Held by Institutions 175.90%
Shares Short (Jan 31, 2019) 41.23M
Short Ratio (Jan 31, 2019) 49.49
Short % of Float (Jan 31, 2019) 44.13%
Short % of Shares Outstanding (Jan 31, 2019) 43.31%
Shares Short (prior month Dec 31, 2018) 41.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21000/1319
Last Split Date 3Nov 4, 2013